Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure

Blood

Volumn 95, Issue 6, 2000, Pages 2093-2097

  West, Robert R ^b   Stafford, D A ^c   White, A D ^c   Bowen, D T ^c   Padua, R A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 5; CHROMOSOME 7; CONTROLLED STUDY; CYTOGENETICS; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL;

EID: 0034653494     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.6.2093     Document Type: Article

References (38)

1. Geddes AD, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome. Br J Haematol. 1990; 76:194.
2. Greenberg P, Cox C, Lebeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89: 2079.
3. White AD, Hoy TG, Jacobs A. Extended cytogenetic follow-up and clinical progress in patients with myelodysplastic syndromes (MDS). Leuk Lymphoma. 1994;12:401.
4. Suciu S, Kuse R, Weh HJ, Hossfeld DK. Results of chromosome-studies and their relation to morphology, course, and prognosis in 120 patients with denovo myelodysplastic syndrome. Cancer Genet Cytogenet. 1990;44:15.
5. Larson RA, Lebeau MM, Vardiman JW, Rowley JD. Myeloid leukemia after hematotoxins. Environ Health Perspect. 1996;104:1303.
6. Vanleeuwen FE. Risk of acute myelogenous leukemia and myelodysplasia following cancer-treatment Baillieres Clin Haematol. 1996;9:57.
7. Carter G, Hughes DC, Clark RE, et al. Ras mutations in patients following cytotoxic therapy for lymphoma. Oncogene. 1990;5:411.
8. Baker A, Cachia P, Ridge S, et al. Fms mutations in patients following cylotoxic therapy for lymphoma. Leuk Res. 1995;19:309.
9. Taylor C, Hughes DC, Zappone E, et al. A screen for RAS mutations in individuals at risk of secondary leukemia due to occupational exposure to petrochemicals. Leuk Res. 1995;19:299.
10. Cachia PG, Taylor C, Thompson PW, et al. Nondysplastic myelodysplasia. Leukemia. 1994;8: 677.
11. White AD, Jones BM, Clark RE, Jacobs A. Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma. Carcinogenesis. 1992;13:1095.
12. West RR, Stafford DA, Farrow A, Jacobs A. Occupational and environmental exposures and myelodysplasia - a case-control study. Leuk Res. 1995;19:127.
13. Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer JM, Fenaux P. Exposure to occupational and environmental-factors in myelodysplastic syndromes - preliminary-results of a case-control study. Leukemia. 1995;9:693.
14. Aul C, Bowen DT, Yoshida Y. Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica. 1998;83:71.
15. Yin SN, Hayes RB, Linet MS, et al. A cohort study of cancer among benzene-exposed workers in China - overall results. Am J Ind Med. 1996;29: 227.
16. 609C->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res. 1997;57:2839.
17. Zhang LP, Wang YX, Shang N, Smith MT. Benzene metabolites induce the loss and long arm deletion of chromosomes 5 and 7 in human lymphocytes. Leuk Res. 1998;22:105.
18. Mitelman MF, Brand L, Nilsson PG. Relation array occupational exposure to potential mutagenic carcinogenic agents, clinical findings and bone marrow chromosomes in acute lymphocytic leukemia. Blood. 1978;52:1229.
19. Golomb HM, Alimena G, Rowley JD, Vardiman JW, Testa JR, Sovik C. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982;60:404.
20. Rowley JD, Golomb HM. The 4th international workshop on chromosomes in leukemia - a prospective study of acute nonlymphocytic leukemia Chicago, Illinois, U S A, September 2-7, 1982. Cancer Genet Cytogenet. 1984;11:249.
21. Fagioli F, Cuneo A, Piva N, et al. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. Cancer. 1992; 70:77.
22. Crane MM, Strom SS, Halabi S, et al. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev. 1996;5:639.
23. Harnden DG, Klinger HP. An international system for cytogenetic nomenclature. In: Cytogenetics and Cell Genetics. Basel: Karger; 1985.
24. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1949;12:153.
25. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford: Blackwell; 1987.
26. Vineis P, Avanzi GC, Giovinazzo B, Ponzio G, Cambrin GR, Ciccone G. Cytogenetics and occupational exposure to solvents: a pilot study on leukemias and myelodysplastic disorders. Tumori. 1990;76:350.
27. Narod SA, Dube ID. Occupational history and involvement of chromosomes 5 and 7 in acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1989;38:261.
28. Rigolin GM, Cuneo A, Robert MG, et al. Exposure to myelotoxic agents and myelodysplasia: case-conlrol study and correlation with clinicobiological findings. Br J Haematol. 1998;103:189.
29. US Department of Health and Human Services. Report on Carcinogens. 8th ed. Summary 1998.
30. Yager JW, Wiencke JK. Enhancement of chromosomal damage by arsenic - implications for mechanism. Environ Health Perspect. 1993; 101:79.
31. Chen Z, Chen GO, Shi XG, et al. Use of arsenic trioxide (As203) in the treatment of acute promyelocytic leukemia (APL). 1. Arsenic causes both apoptosis and partial differentiation of NB4 and fresh APL cells in vitro and in vivo. Blood. 1996; 88:864.
32. Akao Y, Mizoguchi H, Kojima S, Naoe T, Ohishi N, Yagi K. Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein (Full text delivery). Br J Haematol. 1998;102:1055.
33. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268.
34. Kishimoto T. Cancer due to asbestos exposure. Chest. 1992;101:58.
35. Takeuchi T, Morimoto K. Crocidolite asbestos increased 8-hydroxydeoxyguanosine levels in cellular DNA of a human promyelocytic leukemia-cell line, HL-60. Carcinogenesis. 1994;15:635.
36. Li YB, Trush MA. DMA-damage resulting from the oxidation of hydroquinone by copper - role for a cu(li)/Cu(l) Redox cycle and reactive oxygen generation. Carcinogenesis. 1993;14:1303.
37. Au WW, Wilkinson GS, Tyring SK, et al. Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect. 1996;104:579.
38. Rothman N, Haas R, Hayes RB, et al. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin-a locus in exposed humans. Proc Natl Acad Sci U S A. 1995; 92:4069.